Detalhe da pesquisa
1.
Human Herpesvirus-6 Reactivation and Disease Are Infrequent in Chimeric Antigen Receptor T-cell Therapy Recipients.
Blood
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635788
2.
Unveiling the link between genetic alterations in gamma secretase and BCMA surface density in multiple myeloma.
Br J Haematol
; 204(2): 391-392, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014717
3.
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN.
Am J Hematol
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622840
4.
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Lancet Oncol
; 24(7): 811-822, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414012
5.
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Blood
; 137(3): 323-335, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967009
6.
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
Blood
; 136(8): 936-945, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325490
7.
Diagnosis and Management of Multiple Myeloma: A Review.
JAMA
; 327(5): 464-477, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35103762
8.
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.
Blood
; 134(19): 1585-1597, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558469
9.
Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies.
Future Oncol
; 17(27): 3549-3560, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34154392
10.
The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.
Biol Blood Marrow Transplant
; 26(12): 2372-2377, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846200
11.
Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy.
Br J Haematol
; 189(6): 1119-1126, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030732
12.
Association between dexamethasone exposure and visually significant cataracts in multiple myeloma.
Am J Hematol
; 99(1): E12-E14, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37853832
13.
Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.
Biol Blood Marrow Transplant
; 24(7): 1386-1391, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481870
14.
Plasma cell diseases and organ transplant: A comprehensive review.
Am J Transplant
; 18(5): 1046-1058, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29524307
15.
Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma.
Br J Haematol
; 176(4): 583-590, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28055107
16.
Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants.
Am Heart J
; 184: 150-155, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28224930
17.
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.
Biol Blood Marrow Transplant
; 22(2): 380-385, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26348890
18.
Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation.
Anticancer Drugs
; 26(9): 974-83, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26237500
19.
Management of Acute Myeloid Leukemia in the Intensive Care Setting.
J Intensive Care Med
; 30(7): 375-84, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24756309
20.
Mitigating time toxicity in lymphoma and multiple myeloma.
Leuk Lymphoma
; : 1-12, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38749027